|
Resistance rates in different studies in animals
| | | | |
|
Penicillin(265)
|
(72–88)
|
(225/265)
|
(85%)
|
Mohammed et al. (2018), Suleiman and Mdegela (2018)
|
|
Ampicillin (99)
|
(62–100)
|
(72/99)
|
(73%)
|
Katakweba et al. (2016), Kashoma et al. (2018)
|
|
Tetracycline (364)
|
(16–73)
|
(110/364)
|
(30%)
|
Katakweba et al. (2016), Mohammed et al. (2018), Kashoma et al. (2018), Suleiman and Mdegela (2018)
|
|
Erythromycin (301)
|
(5–23)
|
(28/301)
|
(9%)
|
Kashoma et al. (2018), Suleiman and Mdegela (2018)
|
|
Gentamicin (99)
|
(6–25)
|
(4/99)
|
(4%)
|
Katakweba et al. (2016), Kashoma et al. (2018)
|
|
Co-trimoxazole (132)
|
(22–40)
|
(42/132)
|
(32%)
|
Mohammed et al. (2018), Kashoma et al. (2018)
|
|
Vancomycin (132)
|
(2–11)
|
(10/132)
|
(8%)
|
Katakweba et al. (2016), Mohammed et al. (2018), Kashoma et al. (2018)
|
|
Amoxicillin (217)*
|
(47)
|
(102/217)
|
(47%)
|
Suleiman and Mdegela (2018)
|
|
Cephalexin (217)*
|
(30)
|
(64/217)
|
(30%)
|
Suleiman and Mdegela (2018)
|
|
Oxacillin (147)
|
(0–34)
|
(25/147)
|
(17%)
|
Katakweba et al. (2016), Mohammed et al. (2018), Kashoma et al. (2018)
|
|
Cefoxitin (132)
|
(4–17)
|
(13/132)
|
(10%)
|
Mohammed et al. (2018), Kashoma et al. (2018)
|
